Study Title
Phase II Trial of 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
Study Details
Description:
Identifying medium- and high-risk prostate cancer early may allow for treatments to work. But identification can be hard. Researchers want to see if a radiotracer used during PET scans can help.
Sponsor:
National Cancer Institute
Government Study Link:
NCT05155046 - Click here to see study onClinicalTrials.gov